Previous Close | 0.0360 |
Open | 0.0325 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0310 - 0.0355 |
52 Week Range | 0.0200 - 0.1830 |
Volume | |
Avg. Volume | 174,148 |
Market Cap | 6.618M |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1240 |
Earnings Date | Nov 29, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (an "MCTO") with the British Columbia Securities Commission on the ...
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") is providing a status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (a "MCTO") with the British Columbia Securities Commission on the basis that the Comp
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (a "MCTO") with the British Columbia Securities Commission on the basis that